vs
Krystal Biotech, Inc.（KRYS）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是Krystal Biotech, Inc.的1.1倍（$117.7M vs $107.1M），Krystal Biotech, Inc.净利率更高（48.0% vs -10.8%，领先58.7%），Krystal Biotech, Inc.同比增速更快（17.5% vs -19.2%），Krystal Biotech, Inc.自由现金流更多（$75.4M vs $15.6M），过去两年Krystal Biotech, Inc.的营收复合增速更高（53.8% vs -11.8%）
Krystal Biotech是一家处于临床阶段的生物技术企业，专注于研发和商业化针对罕见重症皮肤病的新型基因疗法，主要面向北美和欧洲市场，服务缺乏有效常规治疗方案的单基因皮肤病患者。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
KRYS vs RGP — 直观对比
营收规模更大
RGP
是对方的1.1倍
$107.1M
营收增速更快
KRYS
高出36.7%
-19.2%
净利率更高
KRYS
高出58.7%
-10.8%
自由现金流更多
KRYS
多$59.8M
$15.6M
两年增速更快
KRYS
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $107.1M | $117.7M |
| 净利润 | $51.4M | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 41.5% | -10.3% |
| 净利率 | 48.0% | -10.8% |
| 营收同比 | 17.5% | -19.2% |
| 净利润同比 | 13.0% | 81.6% |
| 每股收益（稀释后） | $1.69 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRYSRGP
| Q4 25 | $107.1M | $117.7M | ||
| Q3 25 | $97.8M | $120.2M | ||
| Q2 25 | $96.0M | $139.3M | ||
| Q1 25 | $88.2M | $129.4M | ||
| Q4 24 | $91.1M | $145.6M | ||
| Q3 24 | $83.8M | $136.9M | ||
| Q2 24 | $70.3M | $148.2M | ||
| Q1 24 | $45.3M | $151.3M |
净利润KRYSRGP
| Q4 25 | $51.4M | $-12.7M | ||
| Q3 25 | $79.4M | $-2.4M | ||
| Q2 25 | $38.3M | $-73.3M | ||
| Q1 25 | $35.7M | $-44.1M | ||
| Q4 24 | $45.5M | $-68.7M | ||
| Q3 24 | $27.2M | $-5.7M | ||
| Q2 24 | $15.6M | $10.5M | ||
| Q1 24 | $932.0K | $2.5M |
毛利率KRYSRGP
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 40.2% | ||
| Q1 25 | — | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
营业利润率KRYSRGP
| Q4 25 | 41.5% | -10.3% | ||
| Q3 25 | 42.3% | -1.7% | ||
| Q2 25 | 40.9% | -47.0% | ||
| Q1 25 | 41.0% | -38.4% | ||
| Q4 24 | 45.4% | -52.7% | ||
| Q3 24 | 26.8% | -3.5% | ||
| Q2 24 | 12.2% | 7.6% | ||
| Q1 24 | -14.8% | 2.8% |
净利率KRYSRGP
| Q4 25 | 48.0% | -10.8% | ||
| Q3 25 | 81.2% | -2.0% | ||
| Q2 25 | 39.9% | -52.6% | ||
| Q1 25 | 40.5% | -34.0% | ||
| Q4 24 | 49.9% | -47.2% | ||
| Q3 24 | 32.4% | -4.2% | ||
| Q2 24 | 22.2% | 7.1% | ||
| Q1 24 | 2.1% | 1.7% |
每股收益（稀释后）KRYSRGP
| Q4 25 | $1.69 | $-0.38 | ||
| Q3 25 | $2.66 | $-0.07 | ||
| Q2 25 | $1.29 | $-2.21 | ||
| Q1 25 | $1.20 | $-1.34 | ||
| Q4 24 | $1.53 | $-2.08 | ||
| Q3 24 | $0.91 | $-0.17 | ||
| Q2 24 | $0.53 | $0.31 | ||
| Q1 24 | $0.03 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $496.3M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $194.6M |
| 总资产 | $1.3B | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KRYSRGP
| Q4 25 | $496.3M | $89.8M | ||
| Q3 25 | $392.6M | $77.5M | ||
| Q2 25 | $353.8M | $86.1M | ||
| Q1 25 | $308.8M | $72.5M | ||
| Q4 24 | $344.9M | $78.2M | ||
| Q3 24 | $374.0M | $89.6M | ||
| Q2 24 | $345.8M | $108.9M | ||
| Q1 24 | $359.0M | $113.8M |
股东权益KRYSRGP
| Q4 25 | $1.2B | $194.6M | ||
| Q3 25 | $1.1B | $206.4M | ||
| Q2 25 | $1.0B | $207.1M | ||
| Q1 25 | $984.7M | $277.8M | ||
| Q4 24 | $946.4M | $325.7M | ||
| Q3 24 | $885.8M | $407.2M | ||
| Q2 24 | $838.9M | $418.8M | ||
| Q1 24 | $799.2M | $414.9M |
总资产KRYSRGP
| Q4 25 | $1.3B | $289.3M | ||
| Q3 25 | $1.2B | $287.2M | ||
| Q2 25 | $1.1B | $304.7M | ||
| Q1 25 | $1.1B | $375.6M | ||
| Q4 24 | $1.1B | $424.9M | ||
| Q3 24 | $982.3M | $512.9M | ||
| Q2 24 | $917.7M | $510.9M | ||
| Q1 24 | $853.3M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $77.5M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $75.4M | $15.6M |
| 自由现金流率自由现金流/营收 | 70.4% | 13.2% |
| 资本支出强度资本支出/营收 | 2.0% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | $188.9M | $24.3M |
8季度趋势，按日历期对齐
经营现金流KRYSRGP
| Q4 25 | $77.5M | $15.9M | ||
| Q3 25 | $39.7M | $-7.8M | ||
| Q2 25 | $52.7M | $16.8M | ||
| Q1 25 | $31.0M | $659.0K | ||
| Q4 24 | $52.8M | $1.8M | ||
| Q3 24 | $58.9M | $-309.0K | ||
| Q2 24 | $-4.2M | $3.2M | ||
| Q1 24 | $15.9M | $20.5M |
自由现金流KRYSRGP
| Q4 25 | $75.4M | $15.6M | ||
| Q3 25 | $38.0M | $-8.0M | ||
| Q2 25 | $50.8M | $16.5M | ||
| Q1 25 | $24.8M | $238.0K | ||
| Q4 24 | $52.0M | $61.0K | ||
| Q3 24 | $57.8M | $-575.0K | ||
| Q2 24 | $-5.3M | $3.0M | ||
| Q1 24 | $14.6M | $20.4M |
自由现金流率KRYSRGP
| Q4 25 | 70.4% | 13.2% | ||
| Q3 25 | 38.8% | -6.6% | ||
| Q2 25 | 52.9% | 11.8% | ||
| Q1 25 | 28.1% | 0.2% | ||
| Q4 24 | 57.1% | 0.0% | ||
| Q3 24 | 69.0% | -0.4% | ||
| Q2 24 | -7.5% | 2.1% | ||
| Q1 24 | 32.3% | 13.5% |
资本支出强度KRYSRGP
| Q4 25 | 2.0% | 0.3% | ||
| Q3 25 | 1.7% | 0.1% | ||
| Q2 25 | 2.0% | 0.2% | ||
| Q1 25 | 7.0% | 0.3% | ||
| Q4 24 | 0.9% | 1.2% | ||
| Q3 24 | 1.2% | 0.2% | ||
| Q2 24 | 1.6% | 0.1% | ||
| Q1 24 | 2.8% | 0.1% |
现金转化率KRYSRGP
| Q4 25 | 1.51× | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | -0.27× | 0.30× | ||
| Q1 24 | 17.05× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRYS
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
